Growing community of inventors

East Lyme, CT, United States of America

Mark Maloney

Average Co-Inventor Count = 5.78

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 61

Mark MaloneyEkaterina Albert (11 patents)Mark MaloneyElaine Greer (11 patents)Mark MaloneyStephen Anderson (11 patents)Mark MaloneyShu Yu (11 patents)Mark MaloneyEmily Marie Rigsbee (6 patents)Mark MaloneyEmily Rigsbee (5 patents)Mark MaloneyMark John Pozzo (1 patent)Mark MaloneyMichael John Hawley (1 patent)Mark MaloneyThomas J Fleck (1 patent)Mark MaloneyJavier Magano (1 patent)Mark MaloneyDurgesh Vasant Nadkarni (1 patent)Mark MaloneyJohn Joseph Teixeira, Jr (1 patent)Mark MaloneyOlivier J Marcq (1 patent)Mark MaloneyStephen P Prescott (1 patent)Mark MaloneyMark Maloney (13 patents)Ekaterina AlbertEkaterina Albert (23 patents)Elaine GreerElaine Greer (11 patents)Stephen AndersonStephen Anderson (11 patents)Shu YuShu Yu (11 patents)Emily Marie RigsbeeEmily Marie Rigsbee (12 patents)Emily RigsbeeEmily Rigsbee (6 patents)Mark John PozzoMark John Pozzo (18 patents)Michael John HawleyMichael John Hawley (11 patents)Thomas J FleckThomas J Fleck (5 patents)Javier MaganoJavier Magano (3 patents)Durgesh Vasant NadkarniDurgesh Vasant Nadkarni (2 patents)John Joseph Teixeira, JrJohn Joseph Teixeira, Jr (2 patents)Olivier J MarcqOlivier J Marcq (1 patent)Stephen P PrescottStephen P Prescott (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Pfizer Corporation (12 from 4,455 patents)

2. Pharmacia & Upjohn Company (1 from 523 patents)


13 patents:

1. 12297177 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

2. 12116347 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

3. 11905255 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

4. 11884634 - Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide

5. 11884635 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

6. 11845732 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

7. 11820748 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

8. 11566006 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

9. 10941118 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

10. 10710966 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

11. 10590087 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

12. 9352050 - Processes for preparing peptide conjugates and linkers

13. 7435832 - Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/24/2025
Loading…